These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9284599)

  • 21. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute systemic side-effects of topical timolol for glaucoma].
    Geyer O; Loewenstein A; Gertler-Hertz I; Lazar M
    Harefuah; 1992 Dec; 123(11):460-1, 506. PubMed ID: 1487203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosage cost analysis in glaucoma management.
    Gelvin JB; Goen TM
    J Am Optom Assoc; 1989 Oct; 60(10):768-70. PubMed ID: 2584592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.
    Chiseliţă D; Antohi I; Medvichi R; Danielescu C
    Oftalmologia; 2005; 49(3):39-45. PubMed ID: 16408674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
    Strohmaier K; Snyder E; Adamsons I
    J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Betaxolol and levobunolol: new beta-blocking antiglaucoma agents.
    Tierney DW
    J Am Optom Assoc; 1987 Sep; 58(9):722-7. PubMed ID: 2895783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved lung function tests on changing from topical timolol: non-selective beta-blockade impairs lung function tests in elderly patients.
    Diggory P; Heyworth P; Chau G; McKenzie S; Sharma A; Luke I
    Eye (Lond); 1993; 7 ( Pt 5)():661-3. PubMed ID: 8287989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An advance in ophthalmic pharmacology. The use of the epinephrine pro-drug dipivalyl epinephrine in the treatment of glaucoma.
    Garzia R
    J Am Optom Assoc; 1982 Sep; 53(9):727-30. PubMed ID: 7130613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of adding betaxolol to dipivefrin therapy.
    Weinreb RN; Ritch R; Kushner FH
    Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of antiglaucoma medications on bovine trabecular meshwork cells in vitro.
    Kawa JE; Higginbotham EJ; Chang IL; Yue BY
    Exp Eye Res; 1993 Nov; 57(5):557-65. PubMed ID: 8282042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daily cost of glaucoma medications in China.
    Gao Y; Wu L; Li A
    J Glaucoma; 2007; 16(7):594-7. PubMed ID: 18091176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aphakic cystoid macular edema secondary to betaxolol therapy.
    Hesse RJ; Swan JL
    Ophthalmic Surg; 1988 Aug; 19(8):562-4. PubMed ID: 2902544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of glaucoma with carbonic anhydrase inhibitors in eyewash: medium term retrospective experience with dorzolamide].
    Detry-Morel M; De Hoste F
    Bull Soc Belge Ophtalmol; 1997; 267():157-66. PubMed ID: 9745826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of the C Cap in promoting prescription refill compliance among patients with glaucoma.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Nakahiro RK; Gill MA
    Clin Ther; 1991; 13(3):396-400. PubMed ID: 1954641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levobunolol compared to dipivefrin in African American patients with open angle glaucoma.
    Drake MV; Wilson MR; Harris D; Goodwin L
    J Ocul Pharmacol; 1993; 9(2):91-5. PubMed ID: 8123096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of the effectiveness of beta-blockers for intraocular pressure and visual field in primary open-angle glaucoma].
    Dobre X
    Oftalmologia; 2008; 52(4):95-9. PubMed ID: 19354170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
    Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
    Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade.
    Frishman WH; Kowalski M; Nagnur S; Warshafsky S; Sica D
    Heart Dis; 2001; 3(6):386-97. PubMed ID: 11975823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.